Preclinical study of GKT831 shows rapid regression of cholestatic fibrosis in model of advanced liver fibrosis

NEXT STORY
Motif Bio to Present Iclaprim Data at ASM Microbe 2019
PREV STORY
Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to Treat Patients with Recurrent Glioblastoma

author_avatar
NASDAQ Market News

Trivedi Global, Inc. in Association with Mark Stutheit Announces Research Results of a Biofield Energy Treated Nutraceutical to Mitigate Inflammation and Autoimmune Disorders

Over 40% reduction in expression of inflammatory biomarkersOmaha, Nebraska, USA, June 07, 2018 (GLOBE ...

author_avatar
NASDAQ Market News

Global Antifungal Drugs Market Analysis, Forecast & Opportunities, 2013-2018 & 2023 – Azoles Class Antifungals are Predicted to Hold their Dominant Position in the Market

author_avatar
NASDAQ Market News